(Q36729512)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

main subject

phase III clinical trial

0 references

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

14

Vered Stearns

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

15

Edith A Perez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

5

George W Sledge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

James N Ingle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Paul E Goss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Kathleen I Pritchard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Matthew J Ellis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

G Thomas Budd

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Rafat H Ansari

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

David B Johnson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Richard Tozer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

David P D'Souza

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Haji Chalchal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Silvana Spadafora

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Pedro E R Liedke

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Istvan Lang

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Catherine Elliott

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Karen A Gelmon

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Judy-Anne W Chapman

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Lois E Shepherd

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

28 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

1398-1404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

22 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Patient adherence and persistence with oral anticancer treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Adherence to endocrine therapy for breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Aromatase inhibitors and bone health in women with breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Comparative clinical pharmacology and pharmacokinetic interactions of aromatase inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Toxicity and response criteria of the Eastern Cooperative Oncology Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety upda

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612593

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

5 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23358971

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A comment on futility monitoring

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23358971

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2012.44.7805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23358971%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

23358971

1 reference